Blue sweat: Infectious Pseudochromdrosis Caused by Bacillus Cereus
Sponsor
Oslo University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05507086
Collaborator
(none)
12
1
48
0.3
Study Details
Study Description
Brief Summary
Twelve patients with blue sweat (infectious pseudochromhidrosis) caused by Bacillus cereus.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Case series/observational study. Twelve patients with blue sweat (infectious pseudochromhidrosis) caused by Bacillus cereus. Demography, clinical presentation, diagnosis, treatments, microbiology and causality.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
12 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Blue Sweat - Infectious Pseudochromdrosis Caused by Bacillus Cereus
Actual Study Start Date
:
Jan 1, 2020
Anticipated Primary Completion Date
:
Dec 31, 2022
Anticipated Study Completion Date
:
Dec 31, 2023
Outcome Measures
Primary Outcome Measures
- Remission [1 year]
Descriptive / physical examination
- Repeated bacteriological swab [1 year]
Repeated bacteriological swab if uncertainty in terms of complete remission
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
- Infectious pseudochromhidrosis caused by Bacillus cereus
Exclusion Criteria:
- Other types of blue chromhidrosis
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Microbiology | Lørenskog | Viken | Norway | 1478 |
Sponsors and Collaborators
- Oslo University Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Christoffer Aam Ingvaldsen,
Researcher,
University Hospital, Akershus
ClinicalTrials.gov Identifier:
NCT05507086
Other Study ID Numbers:
- IPCH2
First Posted:
Aug 18, 2022
Last Update Posted:
Aug 23, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Christoffer Aam Ingvaldsen,
Researcher,
University Hospital, Akershus
Additional relevant MeSH terms: